Европейский союз - датский - EMA (European Medicines Agency)

viiv healthcare bv - dolutegravir - hiv infektioner - antivirale midler til systemisk anvendelse - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

2care4 aps - amiodaronhydrochlorid - injektionsvæske, opløsning - 50 mg/ml

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - amiodaronhydrochlorid - tabletter - 100 mg

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

sandoz a/s - amiodaronhydrochlorid - tabletter - 200 mg

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

sanofi a/s - amiodaronhydrochlorid - injektionsvæske, opløsning - 50 mg/ml

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm a/s - amiodaronhydrochlorid - injektionsvæske, opløsning - 50 mg/ml

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

sanofi a/s - amiodaronhydrochlorid - tabletter - 100 mg

Дания - датский - Lægemiddelstyrelsen (Danish Medicines Agency)

sanofi a/s - amiodaronhydrochlorid - tabletter - 200 mg

Европейский союз - датский - EMA (European Medicines Agency)

gilead sciences ireland uc - sofosbuvir, velpatasvir, voxilaprevi - hepatitis c kronisk - antivirale midler til systemisk anvendelse - vosevi is indicated for the treatment of chronic hepatitis c virus (hcv) infection in patients aged 12 years and older and weighing at least 30 kg. (se afsnit 4. 2, 4. 4 og 5.

Европейский союз - датский - EMA (European Medicines Agency)

merck sharp & dohme b.v. - doravirine - hiv infektioner - antivirale midler til systemisk anvendelse - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.